Terkko Navigator / Movement Disorders

Risk of Hospitalization and Death for COVID‐19 in People With Parkinson's Disease or Parkinsonism

Neuroimaging of Anxiety in Parkinson's Disease: A Systematic Review

Dentate Nucleus Neuronal Density: A Postmortem Study of Essential Tremor Versus Control Brains

Is Levodopa Response a Valid Indicator of Parkinson's Disease?

Neurology and Psychiatry Get Closer Again: Lessons From Dystonia

A Distinct EEG Marker of Celiac Disease‐Related Cortical Myoclonus

Proenkephalin Decreases in Cerebrospinal Fluid with Symptom Progression of Huntington's Disease

Levodopa‐Induced Dyskinesia Are Mediated by Cortical Gamma Oscillations in Experimental Parkinsonism

Hot Topic: Epigenetics in Parkinson's Disease: A New Frontier for Disease‐Modifying Therapies

First Case of Parkinsonian‐Pyramidal Syndrome Associated with a TBK1 Mutation

In Vivo Assessment of Neuroinflammation in 4‐Repeat Tauopathies

Antisaccade Latency Is Sensitive to Longitudinal Change of Motor and Cognitive Symptoms in Parkinson's Disease

Immunohistochemical Detection of Synuclein Pathology in Skin in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinsonism

No Change in Prevalence of Impulse Control Disorder Behaviors in Parkinson's Disease During the Last Decade

The Role of Cholesterol inα‐Synuclein and Lewy Body Pathology in GBA1 Parkinson's Disease

Illuminating Cortical Control of Movement in Nonhuman Primates

Reversing a Model of Parkinson's Disease With In Situ Converted Nigral Neurons

Dentate Nucleus Neuronal Density: A Postmortem Study of Essential Tremor Versus Control Brains

Is Levodopa Response a Valid Indicator of Parkinson's Disease?

Neurology and Psychiatry Get Closer Again: Lessons From Dystonia

A Distinct EEG Marker of Celiac Disease‐Related Cortical Myoclonus

Proenkephalin Decreases in Cerebrospinal Fluid with Symptom Progression of Huntington's Disease

Levodopa‐Induced Dyskinesia Are Mediated by Cortical Gamma Oscillations in Experimental Parkinsonism

Hot Topic: Epigenetics in Parkinson's Disease: A New Frontier for Disease‐Modifying Therapies

First Case of Parkinsonian‐Pyramidal Syndrome Associated with a TBK1 Mutation

In Vivo Assessment of Neuroinflammation in 4‐Repeat Tauopathies

Antisaccade Latency Is Sensitive to Longitudinal Change of Motor and Cognitive Symptoms in Parkinson's Disease

Immunohistochemical Detection of Synuclein Pathology in Skin in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinsonism

No Change in Prevalence of Impulse Control Disorder Behaviors in Parkinson's Disease During the Last Decade

The Role of Cholesterol inα‐Synuclein and Lewy Body Pathology in GBA1 Parkinson's Disease

Bilateral Pallidotomy for Dystonia: A Systematic Review

Long‐Term Safety and Clinical Effects of Nilotinib in Parkinson's Disease

A Neurodevelopmental Disorder With Dystonia and Chorea Resulting From Clustering CAMK4 Variants

Resting‐State Functional Connectivity Predicts STN DBS Clinical Response

Perception of Movement in Works of Art: Is the Motor Response a Movement Disorder?

FDG‐PET Patterns Predict Amyloid Deposition and Clinical Profile in Corticobasal Syndrome

Oligodendrocytes, a New Player in the Etiology of Parkinson's Disease

Lessons From George Floyd: Racial Inequalities in the Treatment of Parkinson's Disease

Psychosis‐Like Behavior and Hyperdopaminergic Dysregulation in Human α‐Synuclein BAC Transgenic Rats

Transitional Care for Young People with Neurological Disorders: A Scoping Review with A Focus on Patients with Movement Disorders

Fosmetpantotenate Randomized Controlled Trial in Pantothenate Kinase–Associated Neurodegeneration

From iPS Cells to Rodents and Nonhuman Primates: Filling Gaps in Modeling Parkinson's Disease

Adenosine A2A Receptor Occupancy by Long‐Term Istradefylline Administration in Parkinson's Disease

A Gain‐of‐Function Variant in Dopamine D2 Receptor and Progressive Chorea and Dystonia Phenotype

Risk of hospitalization and death for COVID‐19 in people with Parkinson's disease or parkinsonism

Modernizing Daily Function Assessment in Parkinson's Disease Using Capacity, Perception, and Performance Measures

Seven Solutions for Neuroprotection in Parkinson's Disease

Connectivity Correlates of Anxiety Symptoms in Drug‐Naive Parkinson's Disease Patients

RNF170‐Related Hereditary Spastic Paraplegia: Confirmation by a Novel Mutation

Levodopa Versus Dopamine Agonist After Subthalamic Stimulation in Parkinson's Disease